At a session at ACR Convergence 2022, clinicians discussed different approaches to identify and address the issue of health care disparities among pediatric patients with rheumatologic diseases.
All articles by Tori Rodriguez, MA, LPC, AHC
Findings published in 2020 suggest that irregular sleep schedules may increase CVD risk independent of sleep quality or duration.
Looking at stress and university students during the COVID-19 pandemic.
AMA president Jack Resneck, Jr., MD, and David M. Pariser, MD, FAAD, a dermatologist in private practice, tell us their thoughts and experiences on the challenges patients face in accessing methotrexate.
Gregory M Marcus, MD, MAS, and Jeffrey J. Hsu, MD, PhD, discuss the effect of caffeine and energy supplements on risk for cardiovascular events.
In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
A look into the growing number of cases of stress cardiomyopathy, also known as Takotsubo syndrome, that have been observed during the COVID-19 pandemic.
What are the most effective pharmacologic therapies recommended for treating patients with moderate to severe COVID-19? Drs Sarina Sahetya of Johns Hopkins University, Matthew Exline of Ohio State University, and Minjoung Go of Stanford University offer their perspectives.
Elizabeth Profita, MD, and Gerard J. Boyle, MD, FACC, discuss myocarditis in younger populations and how pediatric cardiologists should respond with treatment.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
Katy Leung, MD, provides insight into the existing sex and gender differences between men and women with axial spondyloarthritis.
A significant number of cases of post-COVID-19 myocarditis have been reported.
Recommendations for clinicians regarding the treatment of skin infections in people who inject drugs was provided in an interview with Raja Sivamani, MD, MS, AP.
Drs Kronzer and Tatangelo discuss the major comorbidities of patients before and after the diagnosis of rheumatoid arthritis and how to manage these disorders.
Even before the COVID-19 pandemic began, concerning mental health trends and major treatment gaps were noted among adolescents. We spoke with Cécile Rousseau, MD, researcher, psychiatrist, and professor in the division of social and transcultural psychiatry at McGill University in Montreal, Canada about the impact of the COVID-19 pandemic on adolescent mental health.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.
Drs Jeffrey A. Sparks and Vivian P. Bykerk join the ongoing debate about methotrexate as a potential risk factor for lung disease in rheumatoid arthritis and the current clinical implications.
Insufficient pain management during childhood immunizations may lead to increased fear of needles and later health care avoidance.
For patients with rheumatoid arthritis, studies show the benefits of certain dietary patterns and nutrients, including their possible protective effects on disease risk and progression.
An overview of the risk for infections during targeted and biologic therapies in rheumatoid arthritis and psoriatic arthritis.
Rheumatologist Jeff Stark, MD, discusses the diagnostic code developed specifically for nonradiographic axial spondyloarthritis.
Dr Brian LaMoreaux emphasized the importance of screening, addressing manifestations, and physician education in improving patient outcomes in gout.
Jemima Albayda, MD, discusses the cardiac complications in idiopathic inflammatory myopathies.
Barriers to pharmacotherapy for osteoporosis warrant further investigation in order to reduce the elevated mortality and morbidity rates associated with the disease.
Research has consistently demonstrated racial and ethnic disparities among patients with rheumatoid arthritis. Rheumatology Advisor interviewed one of the authors of a recent study, Isabel Castrejon, to learn more about these disparities and any potential solutions.
An expert from the Division of Rheumatology and Clinical Immunology at the University of Pittsburgh discusses reproductive health and family planning in women with rheumatic diseases.
A greater understanding of the mechanisms that promote hypertension in rheumatic diseases will provide insight into understanding primary hypertension.
Research has shown that Disease Activity Scores are inflated as a result of pain reports that do not reflect actual disease activity in rheumatoid arthritis.
Latest News Your top articles for WednesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses